Wellen KE, Hotamisligil GS: Inflammation, stress, and diabetes. J Clin Invest 2005, 115: 1111-1119.
Article
PubMed Central
CAS
PubMed
Google Scholar
Benomar Y, Wetzler S, Larue-Achagiotis C, Djiane J, Tome D, Taouis M: In vivo leptin infusion impairs insulin and leptin signalling in liver and hypothalamus. Mol Cell Endocrinol 2005, 242: 59-66. 10.1016/j.mce.2005.07.003
Article
CAS
PubMed
Google Scholar
Ahima RS, Lazar MA: Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 2008, 22: 1023-1031. 10.1210/me.2007-0529
Article
PubMed Central
CAS
PubMed
Google Scholar
Kremen J, Dolinkova M, Krajickova J, Blaha J, Anderlova K, Lacinova Z, Haluzikova D, Bosanska L, Vokurka M, Svacina S, Haluzik M: Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab 2006, 91: 4620-4627. 10.1210/jc.2006-1044
Article
CAS
PubMed
Google Scholar
Anderson PD, Mehta NN, Wolfe ML, Hinkle CC, Pruscino L, Comiskey LL, Tabita-Martinez J, Sellers KF, Rickels MR, Ahima RS, Reilly MP: Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab 2007, 92: 2272-2279. 10.1210/jc.2006-2545
Article
CAS
PubMed
Google Scholar
Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS: Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004, 109: 1497-1502. 10.1161/01.CIR.0000121747.71054.79
Article
CAS
PubMed
Google Scholar
Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345: 1359-1367. 10.1056/NEJMoa011300
Article
PubMed
Google Scholar
Traynor C, Hall GM: Endocrine and metabolic changes during surgery: anaesthetic implications. Br J Anaesth 1981, 53: 153-160. 10.1093/bja/53.2.153
Article
CAS
PubMed
Google Scholar
Jakob SM, Ensinger H, Takala J: Metabolic changes after cardiac surgery. Curr Opin Clin Nutr Metab Care 2001, 4: 149-155. 10.1097/00075197-200103000-00012
Article
CAS
PubMed
Google Scholar
Lin B, Morris DW, Chou JY: Hepatocyte nuclear factor 1α is an accessory factor required for activation of glucose-6-phosphatase gene transcription by glucocorticoids. DNA Cell Biol 1998, 17: 967-74.
Article
CAS
PubMed
Google Scholar
Leboeuf B, Renold AE, Cahill GF Jr: Studies on rat adipose tissue in vitro. IX. Further effects cortisol on glucose metabolism. J Biol Chem 1962, 237: 988-991.
CAS
PubMed
Google Scholar
Mooney RA: Counterpoint: interleukin-6 does not have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol 2007, 102: 816-818. 10.1152/japplphysiol.01208a.2006
Article
CAS
PubMed
Google Scholar
Pedersen BK, Febbraio MA: Point: interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol 2007, 102: 814-816. 10.1152/japplphysiol.01208.2006
Article
CAS
PubMed
Google Scholar
Muller S, Martin S, Koenig W, Hanifi-Moghaddam P, Rathmann W, Haastert B, Giani G, Illig T, Thorand B, Kolb H: Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors. Diabetologia 2002, 45: 805-812. 10.1007/s00125-002-0829-2
Article
CAS
PubMed
Google Scholar
Pickup JC, Chusney GD, Thomas SM, Burt D: Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes. Life Sci 2000, 67: 291-300. 10.1016/S0024-3205(00)00622-6
Article
CAS
PubMed
Google Scholar
Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001, 280: E745-751.
CAS
PubMed
Google Scholar
Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286: 327-334. 10.1001/jama.286.3.327
Article
CAS
PubMed
Google Scholar
Stith RD, Luo J: Endocrine and carbohydrate responses to interleukin-6 in vivo. Circ Shock 1994, 44: 210-215.
CAS
PubMed
Google Scholar
Klover PJ, Zimmers TA, Koniaris LG, Mooney RA: Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 2003, 52: 2784-2789. 10.2337/diabetes.52.11.2784
Article
CAS
PubMed
Google Scholar
Klover PJ, Clementi AH, Mooney RA: Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 2005, 146: 3417-3427. 10.1210/en.2004-1468
Article
CAS
PubMed
Google Scholar
Weigert C, Hennige AM, Lehmann R, Brodbeck K, Baumgartner F, Schauble M, Haring HU, Schleicher ED: Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells. J Biol Chem 2006, 281: 7060-7067. 10.1074/jbc.M509782200
Article
CAS
PubMed
Google Scholar
Krogh-Madsen R, Plomgaard P, Moller K, Mittendorfer B, Pedersen BK: Influence of TNF-α and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans. Am J Physiol Endocrinol Metab 2006, 291: E108-E114. 10.1152/ajpendo.00471.2005
Article
CAS
PubMed
Google Scholar
Matarese G, Moschos S, Mantzoros CS: Leptin in immunology. J Immunol 2005, 174: 3137-3142.
Article
CAS
PubMed
Google Scholar
Gainsford T, Willson TA, Metcalf D, Handman E, McFarlane C, Ng A, Nicola NA, Alexander WS, Hilton DJ: Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci USA 1996, 93: 14564-14568. 10.1073/pnas.93.25.14564
Article
PubMed Central
CAS
PubMed
Google Scholar
Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, Huffnagle GB: Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol 2002, 168: 4018-4024.
Article
CAS
PubMed
Google Scholar
Ozata M, Ozdemir IC, Licinio J: Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999, 84: 3686-3895. 10.1210/jc.84.10.3686
Article
CAS
PubMed
Google Scholar
Ceddia RB, Koistinen HA, Zierath JR, Sweeney G: Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J 2002, 16: 1163-1176. 10.1096/fj.02-0158rev
Article
CAS
PubMed
Google Scholar
Sivitz WI, Walsh SA, Morgan DA, Thomas MJ, Haynes WG: Effects of leptin on insulin sensitivity in normal rats. Endocrinology 1997, 138: 3395-3401. 10.1210/en.138.8.3395
CAS
PubMed
Google Scholar
Muzzin P, Eisensmith RC, Copeland KC, Woo SL: Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc Natl Acad Sci USA 1996, 93: 14804-14808. 10.1073/pnas.93.25.14804
Article
PubMed Central
CAS
PubMed
Google Scholar
Zierath JR, Frevert EU, Ryder JW, Berggren PO, Kahn BB: Evidence against a direct effect of leptin on glucose transport in skeletal muscle and adipocytes. Diabetes 1998, 47: 1-4. 10.2337/diabetes.47.1.1
Article
CAS
PubMed
Google Scholar
Niswender KD, Magnuson MA: Obesity and the beta cell: lessons from leptin. J Clin Invest 2007, 117: 2753-2756. 10.1172/JCI33528
Article
PubMed Central
CAS
PubMed
Google Scholar
Howard JK, Flier JS: Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol Metab 2006, 17: 365-371. 10.1016/j.tem.2006.09.007
Article
CAS
PubMed
Google Scholar
Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7: 941-946. 10.1038/90984
Article
CAS
PubMed
Google Scholar
Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86: 1930-1935. 10.1210/jc.86.5.1930
Article
CAS
PubMed
Google Scholar
Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature 2001, 409: 307-312. 10.1038/35053000
Article
CAS
PubMed
Google Scholar
Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA: An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 2004, 1: e45. 10.1371/journal.pmed.0010045
Article
PubMed Central
PubMed
Google Scholar
Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 1997, 389: 610-614. 10.1038/39335
Article
CAS
PubMed
Google Scholar
Michie HR, Spriggs DR, Manogue KR, Sherman ML, Revhaug A, O'Dwyer ST, Arthur K, Dinarello CA, Cerami A, Wolff SM, et al.: Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 1988, 104: 280-286.
CAS
PubMed
Google Scholar
Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J, CORTICUS Study Group: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358: 111-124. 10.1056/NEJMoa071366
Article
CAS
PubMed
Google Scholar